NUPATHE CLOSES $15 MILLION FINANCING

NuPathe Inc., a privately held specialty pharmaceutical company, has completed a $15 million round of private equity financing. The Series A financing will support NuPathe's clinical programs related to therapeutic products to treat migraine and other CNS disorders. Yahoo News (http://biz.yahoo.com/prnews/060913/nyw059.html?.v=72)